James River Group Holdings (JRVR) Q3 2024 earnings summary

Executive summary

• Reported a Q3 2024 net loss from continuing operations of $40.7 million ($1.07 per diluted share), driven by $57.0 million of adverse reserve development and strategic reinsurance actions, including a $52.2 million charge from a new reinsurance contract.

• Announced a strategic partnership with Enstar Group, including a $12.5 million equity investment, a $75 million adverse development cover, and consulting collaboration.

• Amended Gallatin Point preferred shares, converting $37.5 million to common equity and capping the dividend rate, reducing fixed charges.

• Closed the sale of JRG Reinsurance Company Ltd. in April 2024, resulting in discontinued operations and a $2.7 million loss on disposal.

• Board concluded the strategic review process, positioning the company for future value creation and ongoing evaluation of opportunities.

Financial highlights

• Gross written premiums were $330.4 million in Q3 2024, down 4% year-over-year; net written premiums were $147.3 million, up 1%.

• Net earned premiums declined 13% to $159.7 million; net investment income rose 8.1% to $23.6 million; net realized and unrealized investment gains were $4.2 million.

• E&S segment produced an underwriting loss of $50.2 million (combined ratio 136.1%) in Q3 2024, mainly due to adverse reserve development.

• Specialty Admitted segment had a combined ratio of 91.3% and $1.8 million underwriting profit in Q3 2024.

• Adjusted net operating loss was $28.2 million ($0.74 per share) in Q3 2024.

Outlook and guidance

• Confident in the profitability of 2023 and 2024 accident years, with strong submission and rate growth expected to continue.

• Redomiciling to the U.S. in 2025 is expected to reduce the effective tax rate closer to the U.S. statutory rate.

• Expense ratio expected to normalize around 28% going forward.

• Strategic actions, including capital raise and reinsurance, position the E&S franchise to capitalize on robust market conditions.

• Board will continue to evaluate beneficial opportunities post-strategic review.